Tobias Lurk, global product performance manager at TÜV SÜD Management Service, explores how pharmaceutical manufacturers can navigate the revised ISO 14001 standard by strengthening existing management systems rather than starting from scratch.
A new survey reveals widespread concern among respondents about counterfeit medication, with six in 10 worried their prescribed drugs might be fake or substandard.
Thomas Halfmann, smart factory advisor at eschbach, and Andreas Eschbach, CEO and founder of Eschbach, outline five steps manufacturers can take to break down these barriers and realise the vision of the adaptive plant.
Barry O’Neill, EHS manager at Gaelic Laboratories, explains the role of pharma manufacturers in managing the spread of AMR, and the steps they should take to do this effectively.
Reap Consulting discusses how patient compliance to prescription medications continues to be a global problem costing society billions, and resulting in unnecessary suffering for millions of people every year.
In aseptic manufacturing, the most significant risk has never been the equipment itself. The most quantitatively significant risk has been the people working in the classified environment in which the equipment is installed.
Klaus Dierolf, group head of project management at Schubert Packaging Systems, and Daniel Greb, head of image processing at Gerhard Schubert look at camera-based clearance in pharmaceutical production.
